These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7147357)

  • 41. Vindesine in the treatment of squamous cell carcinoma (WHO I), adenocarcinoma (WHO III), and large cell carcinoma (WHO IV) of the lung.
    Ferrazzi E; Zagonel V; Vinante O; Galligioni E; Pappagallo GL; Cartei G; Fiorentino MV
    Tumori; 1982 Dec; 68(6):531-5. PubMed ID: 6301122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multicentre phase II trial of vindesine in malignant melanoma.
    Carmichael J; Atkinson RJ; Calman KC; Mackie RM; Naysmith AM; Smyth JF
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1293-5. PubMed ID: 6891927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vindesine in plasma cell tumors.
    Salvagno L; Paccagnella A; Chiarion Sileni V; De Besi P; Frizzarin M; Casara D; Fiorentino MV
    Tumori; 1985 Dec; 71(6):533-6. PubMed ID: 4082286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH
    Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vindesine. A review of phase-II trials.
    Gralla RJ; Tan CT; Young CW
    Cancer Chemother Pharmacol; 1979; 2(4):271-4. PubMed ID: 455587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I evaluation of vindesine in children: a Southwest Oncology Group pilot study.
    Komp D; Vats T; Shepherd DA; Vietti T; Hoogstraten B; Haas CD
    Med Pediatr Oncol; 1980; 8(3):243-50. PubMed ID: 7193278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Phase II study of the treatment of CML blast crisis with vindesine and prednisone].
    Jehn U; Mezger J
    Onkologie; 1984 Dec; 7(6):342-5. PubMed ID: 6396561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequential combination of methotrexate and vindesine in previously treated children with acute leukemia. A phase I-II study.
    Miller LP; Hancock C; Miller DR; Chello PL; Sirotnak FM; Tan CT
    Am J Clin Oncol; 1984 Oct; 7(5):465-70. PubMed ID: 6594925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A presumed transient hemolytic reaction following vinca alkaloids administration in patients with hematological malignancies].
    Iwata N; Wakamatsu E; Oike S; Umegae S; Omine M; Maekawa T; Tsuchiya J
    Rinsho Ketsueki; 1984 May; 25(5):649-54. PubMed ID: 6590896
    [No Abstract]   [Full Text] [Related]  

  • 50. Phase II trial of vindesine in advanced neoplastic disease.
    Stambaugh JE
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():75-9. PubMed ID: 7438126
    [No Abstract]   [Full Text] [Related]  

  • 51. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
    Miller TP; Jones SE; Chester AB; Dorr RT
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127
    [No Abstract]   [Full Text] [Related]  

  • 52. Vindesine in the treatment of refractory haematological malignant diseases.
    Young GA; Jurd J; Vincent PC
    Med J Aust; 1985 Feb; 142(3):189-90. PubMed ID: 3969034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II trial of vindesine in patients with squamous cell cancer of the head and neck.
    Sledge GW; Clark GM; Griffin C; Mattox DE; Von Hoff DD
    Am J Clin Oncol; 1984 Jun; 7(3):209-11. PubMed ID: 6731343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract]   [Full Text] [Related]  

  • 55. Vindesine in the treatment of malignant mesothelioma: a phase II study.
    Kelsen D; Gralla R; Cheng E; Martini N
    Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer.
    Fuks JZ; Patel H; Van Echo DA; Hornedo J; Aisner J
    Med Pediatr Oncol; 1985; 13(2):73-7. PubMed ID: 4039026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
    Furnas BE; Williams SD; Einhorn LH; Cobleigh MA
    Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid.
    Cersosimo RJ; Bromer R; Licciardello JT; Hong WK
    Pharmacotherapy; 1983; 3(5):259-74. PubMed ID: 6359081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
    Shibuya M; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1808-13. PubMed ID: 6307176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma.
    Fuks JZ; Egorin MJ; Aisner J; Van Echo DA; Ostrow S; Bachur NR; Wiernik PH
    Cancer Chemother Pharmacol; 1983; 10(2):104-8. PubMed ID: 6299598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.